DiaMedica Therapeutics Inc. (DMAC) DCF Valuation

DiaMedica Therapeutics Inc. (DMAC) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

DiaMedica Therapeutics Inc. (DMAC) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Enhance your investment choices with the DiaMedica Therapeutics Inc. (DMAC) DCF Calculator! Explore genuine financial data for DiaMedica, adjust growth projections and expenses, and instantly observe how these alterations affect the intrinsic value of DMAC.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -10.6 -12.2 -13.6 -14.0 -19.3 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -10.6 -12.3 -13.6 -14.0 -19.3 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 7.9 27.5 45.1 33.5 52.9 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .8 .3 .1 .1 .4
Account Receivables, % 100 100 100 100 100
Inventories .1 .0 .1 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .2 1.1 .5 .7 .9 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 .0 .0 -.1 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % -0.22236 -0.22236 -0.22236 -0.22236 -0.22236 -0.22236 -0.22236 -0.22236 -0.22236 -0.22236
EBITAT -10.6 -12.3 -13.7 -14.0 -19.4 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -11.4 -10.8 -14.2 -13.7 -19.5 -.6 .0 .0 .0 .0
WACC, % 11.31 11.31 11.31 11.31 11.31 11.31 11.31 11.31 11.31 11.31
PV UFCF
SUM PV UFCF -.5
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -1
Net Debt -4
Equity Value 4
Diluted Shares Outstanding, MM 33
Equity Value Per Share 0.11

What You Will Get

  • Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real DMAC financials.
  • Real-World Data: Historical data and forward-looking estimates (highlighted in the yellow cells).
  • Forecast Flexibility: Modify forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Automatic Calculations: Instantly observe the impact of your inputs on DiaMedica's valuation.
  • Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.

Key Features

  • 🔍 Real-Life DMAC Financials: Pre-filled historical and projected data for DiaMedica Therapeutics Inc.
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate DiaMedica’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize DiaMedica’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  • Step 1: Download the prebuilt Excel template featuring DiaMedica Therapeutics Inc. (DMAC) data.
  • Step 2: Navigate through the pre-filled sheets to grasp the essential metrics.
  • Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly access recalculated results, including DiaMedica’s intrinsic value.
  • Step 5: Utilize the outputs to make informed investment choices or create reports.

Why Choose This Calculator for DiaMedica Therapeutics Inc. (DMAC)?

  • Accurate Data: Utilize real DiaMedica financials for dependable valuation outcomes.
  • Customizable: Tailor essential parameters such as growth rates, WACC, and tax rates to fit your forecasts.
  • Time-Saving: Pre-configured calculations save you from starting from the ground up.
  • Professional-Grade Tool: Crafted for investors, analysts, and consultants in the biotech sector.
  • User-Friendly: Easy-to-navigate interface and clear instructions accommodate all users.

Who Should Use This Product?

  • Investors: Evaluate DiaMedica Therapeutics Inc. (DMAC) for informed stock trading decisions.
  • CFOs and Financial Analysts: Optimize valuation methodologies and validate financial forecasts.
  • Startup Founders: Understand the valuation strategies of biotech firms like DiaMedica.
  • Consultants: Provide comprehensive valuation analyses and reports for clients in the healthcare sector.
  • Students and Educators: Utilize real-time data from DiaMedica to enhance learning in financial valuation practices.

What the Template Contains

  • Historical Data: Includes DiaMedica Therapeutics Inc.'s (DMAC) past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate DiaMedica's (DMAC) intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of DiaMedica's (DMAC) financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.